Evidence map›Paper›PMID 23104229›Full record

ArticleJournal of molecular modeling2013

Drug permeability prediction using PMF method.

Fancui Meng, Weiren Xu

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Free Energy Barriers for Passive Drug Transport through theInternational journal of molecular sciences · 2024
    Article
  2. Article
  3. Article
  4. Crossing of the Cystic Barriers ofMolecules (Basel, Switzerland) · 2021
    Article
  5. [Research Development in Transfersome-Based Drug Delivery System].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fancui MengState Key Laboratory of Drug Delivery Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, People's Republic of China. fancuimeng@yahoo.com.cn
Weiren Xu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug permeability determines the oral availability of drugs via cellular membranes. Poor permeability makes a drug unsuitable for further development. The permeability may be estimated as the free energy change that the drug should overcome through crossing membrane. In this paper the drug permeability was simulated using molecular dynamics method and the potential energy profile was calculated with potential of mean force (PMF) method. The membrane was simulated using DPPC bilayer and three drugs with different permeability were tested. PMF studies on these three drugs show that doxorubicin (low permeability) should pass higher free energy barrier from water to DPPC bilayer center while ibuprofen (high permeability) has a lower energy barrier. Our calculation indicates that the simulation model we built is suitable to predict drug permeability.

Indexed as

Molecular Dynamics SimulationAntibiotics, AntineoplasticAntihypertensive AgentsAnti-Inflammatory Agents, Non-SteroidalAtenololCaco-2 CellsCell LineCell MembraneCell Membrane PermeabilityDoxorubicinHumansIbuprofenPharmaceutical PreparationsQuantitative Structure-Activity RelationshipThermodynamicsAntibiotics, AntineoplasticAntihypertensive AgentsAnti-Inflammatory Agents, Non-SteroidalAtenololDoxorubicinIbuprofenPharmaceutical Preparations

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.